Synaptic Corporation Essay

- On the surface, obtaining support from key opinion leaders, launching manufacturing operations in Costa Rica, and the relationship between James Westcott and Trevor Burns are main problems at Biometra. However, all of this problems were caused because of the organizational structure, lack of communication, and less experienced managers.

Synaptic is a bio technology company that uses a combination of both Information Management (IM) and biological research to develop drugs based on proteins and peptides. Synaptic is comprised of a large Information Management department which consists of multiple divisions within the department. Each division within the IM is in charge of communications and computer systems services, in particular research, manufacturing and infrastructure. The company also employs computational scientists that aid with the research aspect of the product development. The development of the product makes it necessary for both set of parties – the Information Management and the scientists to interact with each

This presentation can be applied to biology as the majority of print regarding biology is moving to digital sources. For example, the large majority of research projects are maintained in online databases that allow for accessible storage, organization, and the ability to quickly scan to find the topic of interest. Thus a current application of this would be the transition of college lab reports and research documentation to digital sources. Another way this presentation could apply to the biology is the way in which biologists collaborate on research. Furthermore, technology has led to significant changes in the way biologists communicate, this is particularly meaningful for science given that the production of scientific knowledge is fundamentally a social process involving information sharing, collaboration and the mobilization of outputs. Additionally, applications such as cloud computing have the potential to change the system of collaboration further by making the process of sharing and multi-authoring documents much easier and by placing ideas within a “social” context to allow even more people to contribute. Thus the technological applications within biology are endless and it has the potential to completely change the way in which biology is studied, taught, and

Securus Technologies is one of the biggest providers of criminal and civil justice technology solutions. It has over 800 products suitable for aiding investigations, corrections, and public safety monitoring by law enforcement agencies or correction centers. Although Securus is based in Dallas, Texas, it serves over 3, 450 public safety, law enforcement agencies, and correction centers that accommodate over 1.2 million inmates across North America. Securus makes the country a safer place to live in by providing services such as investigation biometric analysis, communication options, information management, emergency response, disaster management, and in-mate self-service.

The biotech firm Amgen Inc. gives much attention and time to the planning process. Because the outcomes for a company like Amgen are often very unsure and many employees are quite sceptical about the use of such a planning, the main issue can be described as follows:

Synaptic Corporation is a San Diego, California based biotechnology company who develops pharmaceutical drugs for clinical trials as well as mass distribution (Makarov, n.d., p. 1). Recently, the organization suffered a setback as internal teams failed to collaborate and implement a project that would transition its products from research to production (Makarov, n.d., p. 2). The project failed in part due to the lack of project management, control, and risk practices to address the adverse impacts. Likewise, Synaptic Corporation neglected to utilize its internal Information Management (IM) resources to address and resolve internal software development needs for the scientists in the Computational Biology group (Makarov, n.d., p. 3).

With the emergence of a booming information industry, Taiwan was declared the world’s market leader in numerous high-tech products and offered explosive growth and fertile grounds for businesses in the information industry. Eager to participate in Taiwan’s technology commons, many high-tech companies were attracted to the fertile region in an effort to benefit from the easy market entry and rapid growth opportunities, thus defining the role of distributors with vital importance. Many high-tech suppliers opted to use small, indigenous firms with weak capabilities to lead product distribution for multiple reasons. Due to the unfamiliarity of the local environment as well as the fragmented and dynamic state of the

The biotech firm Amgen Inc. gives much attention and time to the planning process. Because the outcomes for a company like Amgen are often very unsure and many employees are quite sceptical about the use of such a planning, the main issue can be described as follows:

MediSys is a U.S.-based medical device manufacturer. It has been developing IntensCare project, a new medical system for monitoring patients in intensive care units. This project represents the most ambitious move in the company’s 10-year history. The company had invested large finances in this project and the market eagerly awaits its launch. The product development team consisting of people from several functional areas of the company, has been working on the product for six months but is now facing significant problems with the product design, clinical testing, meeting the production deadlines, and their own group dynamics. The pressure had also increased because of competitors also planning to launch similar products within the year. Several team members are concerned about meeting the team 's goals. The relationship between team members is quite tense and it doesn’t promise much progress.

Headquartered in Texas, Teletech Corporation operates under two main business segments: the Telecommunications Services segment, providing various telephone services to business and residential customers and the Products & Systems segment, which manufactures computing and telecommunications equipment. In late 2005, the Securities & Exchange Commission revealed that billionaire Victor Yossarian acquired a 10% stake in Teletech and demanded two seats on the board of directors. He felt that the firm was misusing their resources and not earning a sufficient return. He stated that Teletech should sell off its Product & Systems segment and focus on creating value for the company’s shareholders. A detailed analysis will reveal

Within Synaptic’s organization, there is a distinct disconnect between the Computational Biology and the Information Management (IM) groups. There is a visible lack of knowledge and information sharing between the two. Drastic measures must take place so they can learn to work together to bridge the gap that is between them. Project governance is desperately needed by both the Computational Biology and IM groups as well as the overall organization.

The standard deviation is a number that measure the spread of the data in relation to the mean number. It gives us the scatter of the information in terms of percentage, giving us an idea of how close together or separate our full data set is.

The current chapter on making allies in the work place is a topic with alarming concern. Scientist community in general, may come across these kind of issues at one particular point of time. It is always mandatory to discuss the issues of this kind and resolve them among yourself without giving much prominence to the issue. However, an advice or a good decision from the principle investigator or the head of the project will help a lot in dealing with problems of this kind effectively.

|Industry: Pharmaceutical | | |Jean-Francois Boily, Senior Manager, Finance & Information Systems Teva Neuroscience |

Over time, organizations in pharmaceutical industry have undergone significant technological changes. With these advancements and commercialism organizations are facing challenges to incorporate managing these changes in their operations. The current essay is based on the lawsuit for against GSK (GlaxoSmithKline) for which the company had to pay $250 million. The author will discuss the circumstances which lead to the lawsuit as well as the consequences of the lawsuit and what could be done to escape from this. In brief the essay is a report on the challenge GlaxoSmithKline which faced.